News
20 June 2018
New product to improve workplace mental health
We are very pleased to announce a planned new software product to assess mental health and wellbeing at work, CANTAB BrainHealth™.
Read on
7 June 2018
Cambridge Cognition and University of Bristol in partnership to tackle growing mental health need
Mental and substance use disorders are now the leading cause of disability worldwide, resulting in 23% of all years lost with a global economic loss of a trillion US dollars every year1 which is why we are very pleased to announce a new strategic collaboration and partnership with the University of Bristol to accelerate the development of novel brain health products.
Read on
31 May 2018
New client signs with Cognition Kit software
We’re delighted to announce a new $0.5m contract with a major pharmaceutical company for the use of our Cognition Kit digital health software in a clinical trial.
Read on
30 May 2018
CANTAB Research Grant 2018 - Results
The results of the 2018 CANTAB Research Grant are in! Once again we were overwhelmed by the quality of applications we received – which made it a tough job for our judging panel to narrow the research proposals down.
Read on
10 April 2018
CANTAB Recruit software to be used in two major Phase III drug trials
We’re pleased to announce that our CANTAB Recruit software is now established in two major Phase III trials into Alzheimer’s disease.
Read on
26 March 2018
Cambridge Cognition announces major contract win and funding award
We're pleased to announce the award of a major new pharmaceutical clinical trial contract and a Digital Health Catalyst grant from Innovate UK.
Read on
5 March 2018
Join us at SIRS 2018
Cambridge Cognition are attending the Schizophrenia International Research Society Conference (SIRS): 4th - 8th April 2018
